Table 1.

Correlation of visfatin expression with clinicopathologic characteristics of breast cancer patients

Variables	Item	Visfatin				P^a
		Low		High
		n	%	n	%
Stage	I/II	47	56.6	36	43.4	0.091
	III/IV	8	36.4	14	63.6
Grade	I/II	41	55.4	33	44.6	0.338
	III	14	45.2	17	54.8
Age, y	≤50	32	57.1	24	42.9	0.296
	50	23	46.9	26	53.1
BMI, kg/m²	<24	31	49.2	32	50.8	0.425
	≥24	24	57.1	18	42.9
Tumor size, cm	<2	31	64.6	17	35.4	0.022
	≥2	24	42.1	33	57.9
LN metastasis	0–1	46	57.5	34	42.5	0.060
	≥2	9	36.0	16	64.0
ER	Negative	12	33.3	24	66.7	0.005
	Positive	43	62.3	26	37.7
PR	Negative	17	37.8	28	62.2	0.009
	Positive	38	63.3	22	36.7
Her2/neu	Negative	31	46.3	36	53.7	0.096
	Positive	24	63.2	14	36.8